Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (44)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Melikian, A. A.
Right arrow Articles by Thompson, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Melikian, A. A.
Right arrow Articles by Thompson, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 20, No. 4, 719-726, April 1999
© 1999 Oxford University Press

Determination of the urinary benzene metabolites S-phenylmercapturic acid and trans,trans-muconic acid by liquid chromatography-tandem mass spectrometry

Assieh A. Melikian4, Ray O'Connor1, Agasanur K. Prahalad2, Peifeng Hu3, Heyi Li, Mark Kagan and Seth Thompson

Naylor Dana Institute, American Health Foundation, 1 Dana Road,Valhalla, NY 10595, USA

To investigate how various levels of exposure affect the metabolic activation pathways of benzene in humans and to examine the relationship between urinary metabolites and other biological markers, we have developed a sensitive and specific liquid chromatographic–tandem mass spectrometric assay for simultaneous quantitation of urinary S-phenylmercapturic acid (S-PMA) and trans,trans-muconic acid (t,t-MA). The assay involves spiking urine samples with [13C6]S-PMA and [13C6]t,t-MA as internal standards and clean up of samples by solid-phase extraction with subsequent analysis by liquid chromatography coupled with electrospray-tandem mass spectrometry-selected reaction monitoring (LC–ES–MS/MS–SRM) in the negative ionization mode. The efficacy of this assay was evaluated in human urine specimens from smokers and non-smokers as the benzene-exposed and non-exposed groups. The coefficient of variation of runs on different days (n = 8) for S-PMA was 7% for the sample containing 9.4 µg S-PMA/l urine, that for t,t-MA was 10% for samples containing 0.07 mg t,t-MA/l urine. The mean levels of urinary S-PMA and t,t-MA in smokers were 1.9-fold (P = 0.02) and 2.1-fold (P = 0.03) higher than those in non-smokers. The mean urinary concentration (±SE) was 9.1 ± 1.7 µg S-PMA/g creatinine [median 5.8 µg/g, ranging from not detectable (1 out of 28) to 33.4 µg/g] among smokers. In non-smokers' urine the mean concentration was 4.8 ± 1.1 µg S-PMA/g creatinine (median 3.6 µg/g, ranging from 1.0 to 19.6 µg/g). For t,t-MA in smokers' urine the mean (±SE) was 0.15 ± 0.03 mg/g creatinine (median 0.11 mg/g, ranging from 0.005 to 0.34 mg/g); the corresponding mean value for t,t-MA concentration in non-smokers' urine was 0.07 ± 0.02 mg/g creatinine [median 0.03 mg/g, ranging from undetectable (1 out of 18) to 0.48 mg/g]. There was a correlation between S-PMA and t,t-MA after logarithmic transformation (r = 0.41, P = 0.005, n = 46).

Abbreviations: ES, electrospray; LC, liquid chromatography; MS/MS, tandem mass spectrometry; Q, quadrupole; SAX, strong anion exchanger; S-PMA, S-phenylmercapturic acid; SRM, selected reaction monitoring; t,t-MA, trans,trans-muconic acid.

1 Present address: Schering Plough, Kenilworth, NJ 07033, USA

2 Present address: Curriculum in Toxicology, University of North Carolina, Chapel Hill, NC 27599, USA

3 Present address: Baxter Healthcare Corporation, Round Lake, IL 60073, USA

4 To whom correspondence should be addressed


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
S. Kim, R. Vermeulen, S. Waidyanatha, B. A. Johnson, Q. Lan, N. Rothman, M. T. Smith, L. Zhang, G. Li, M. Shen, et al.
Using urinary biomarkers to elucidate dose-related patterns of human benzene metabolism
Carcinogenesis, April 1, 2006; 27(4): 772 - 781.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.